^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

autologous anti-CD19 (human derived) chimeric antigen receptor T cells

i
Other names: autologous anti-CD19 (human derived) chimeric antigen receptor T cells
Associations
News
Company:
Beijing Boren Hospital
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
News